Abiomed (NASDAQ: ABMD) is a pioneer and global leader in healthcare technology and innovation, with a mission of RECOVERING HEARTS AND SAVING LIVES. Abiomed CEO, Chairman, and President, Michael R. Minogue, has focused the company’s efforts on developing ground-breaking technologies designed to assist or replace the life-sustaining pumping function of the failing heart. The Company’s portfolio of products and services offer healthcare professionals an array of choices across a broad clinical spectrum. From the world’s first total replacement heart to the World’s Smallest Heart Pump, 1/100th the size of the heart with rapid and simple insertion, Abiomed is dedicated to finding ways to bring the most advanced and beneficial technology to patients and physicians.
Company Growth (employees)
Type
Public
HQ
Danvers, US
Size (employees)
908 (est)
ABIOMED is headquartered in Danvers, US

ABIOMED Office Locations

ABIOMED has offices in Danvers and Aachen
Danvers, US (HQ)
22 Cherry Hill Dr
Aachen, DE
3 Neuenhofer Weg

ABIOMED Financials and Metrics

ABIOMED Financials

ABIOMED's revenue was reported to be $445.3 m in FY, 2017
USD

Revenue (Q2, 2018)

132.8 m

Net income (Q2, 2018)

24.5 m

EBIT (Q2, 2018)

31.7 m

Market capitalization (13-Dec-2017)

8.8 b

Cash (30-Sep-2017)

44.5 m
ABIOMED's current market capitalization is $8.8 b.
USDFY, 2014FY, 2015Y, 2016FY, 2017

Revenue

183.6 m230.3 m329.5 m445.3 m

Revenue growth, %

25%43%35%

R&D expense

66.4 m

General and administrative expense

218.2 m
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018

Revenue

44.3 m46.2 m48.8 m51.9 m62 m73.4 m76.4 m85.8 m103 m103 m114.7 m132.5 m132.8 m

R&D expense

7.7 m7.8 m9.1 m8.7 m8.4 m10.2 m11.6 m13.8 m15.7 m18.1 m16.3 m16.9 m19.4 m

General and administrative expense

26.2 m24.4 m31.6 m29.5 m30.1 m37.3 m39.8 m41.9 m51 m53.1 m53.9 m60.6 m60.1 m

Operating expense total

42.9 m41.6 m50.3 m47.8 m48.3 m58.4 m63.5 m68.4 m81.8 m88.4 m89.3 m99.4 m101.1 m
USDFY, 2014FY, 2015FY, 2016FY, 2017

Cash

20.9 m22.4 m48.2 m39 m

Accounts Receivable

24.4 m31.8 m42.8 m54.1 m

Inventories

13.9 m16.8 m26.7 m34.9 m

Current Assets

118 m220.1 m288.4 m327 m
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018

Cash

10.1 m22.6 m34.7 m17.5 m19.5 m40.4 m54.4 m53.2 m38.3 m54.7 m61.1 m44 m44.5 m

Accounts Receivable

21.1 m23 m22.8 m23.1 m28.4 m34.4 m37.1 m36.8 m41.3 m46.6 m50.2 m53.6 m57.3 m

Inventories

15.6 m14.8 m13.9 m13.4 m15.4 m21.2 m23 m25.5 m29.1 m31.5 m32.1 m36.9 m40.6 m

Current Assets

110.6 m119.7 m127.2 m135.3 m160.6 m244.1 m265.4 m281.7 m300.3 m319.9 m333.4 m350.9 m370.2 m
USDFY, 2014FY, 2015FY, 2016FY, 2017

Net Income

7.4 m113.7 m38.1 m52.1 m

Depreciation and Amortization

2.8 m3.3 m6.2 m

Accounts Receivable

(1.3 m)(8 m)(11 m)(11.6 m)

Inventories

(622 k)(7 m)(11 m)(12.3 m)
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Net Income

(664 k)3.7 m(1.7 m)3.8 m12.7 m8.9 m7.7 m10.6 m12.9 m8.9 m15.4 m

Depreciation and Amortization

1.3 m1.9 m

Accounts Receivable

1.9 m123 k22.8 m23.1 m28.4 m34.4 m37.1 m36.8 m41.3 m46.6 m50.2 m

Inventories

(876 k)(69 k)13.9 m13.4 m15.4 m21.2 m23 m25.5 m29.1 m31.5 m32.1 m
USDY, 2017

Revenue/Employee

146.3 k

Financial Leverage

1.1 x
Show all financial metrics

ABIOMED Market Value History

ABIOMED Median Salaries

Source: 15 public H-1B filings from ABIOMED

ABIOMED's Web-traffic and Trends

ABIOMED Online and Social Media Presence

ABIOMED Company Life and Culture

You may also be interested in